Yepes- Corts, Isabel C
A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease
Diabetes, oncology, respiratory diseases, and neurology remain dominant segments
Their abnormal proliferation causes synovial thickening, increased inflammation, and joint damage [237, 238]
When considering study drug discontinuation or use of rescue medication (trial product estimand results), the weight loss resulting from the use of oral semaglutide was up to 5 kg, while that associated with other active comparators ranged from 0.8 to 3.8 kg, and that associated with placebo ranged from 0.1 to + 0.6 kg [35,36,37,38,39,40]